Prevalence of insulin resistance (IR) and impact on treatment in chronic hepatitis C (CHC).

被引：0
|
作者：
Lok, AS
Everhart, JE
Chung, RT
Padmanabhan, L
Shiffman, ML
Everson, GT
Lindsay, KL
Bonkovsky, HL
di Bisceglie, AM
Lee, WM
Ghany, MG
Morishima, C
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] NIDDK, NIH, Bethesda, MD USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] New England Res Inst, Watertown, MA 02172 USA
[5] Virginia Commonwealth Univ, Richmond, VA USA
[6] Univ Colorado, Denver, CO 80202 USA
[7] Univ So Calif, Los Angeles, CA USA
[8] Univ Connecticut, Farmington, CT USA
[9] St Louis Univ, St Louis, MO 63103 USA
[10] Univ Texas SW, Dallas, TX USA
[11] Univ Calif Irvine, Irvine, CA USA
[12] Univ Washington, Seattle, WA 98195 USA
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：314A / 315A
页数：2
相关论文
共 50 条
  • [41] Chemerin, vaspin and insulin resistance in chronic hepatitis C
    Kukla, M.
    Zwirska-Korczala, K.
    Gabriel, A.
    Waluga, M.
    Warakomska, I.
    Szczygiel, B.
    Berdowska, A.
    Mazur, W.
    Wozniak-Grygiel, E.
    Kryczka, W.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (09) : 661 - 667
  • [42] INSULIN RESISTANCE IN CHRONIC HEPATITIS C: SIMILARITIES TO NASH
    Ogino, Hidero
    Nishikawa, Masashi
    Hirai, Satoshi
    Shimatani, Akiyoshi
    Matsuda, Koichiro
    Hiramatsu, Katsushi
    Matsuda, Mitsuru
    Noda, Yatsugi
    HEPATOLOGY, 2009, 50 (04) : 731A - 731A
  • [43] Insulin resistance and its consequences in chronic hepatitis C
    Kukla, Michal
    Piotrowski, Damian
    Waluga, Marek
    Hartleb, Marek
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 1 (01) : 17 - 29
  • [44] Molecular mechanisms of insulin resistance in chronic hepatitis C
    Mark W Douglas
    Jacob George
    World Journal of Gastroenterology, 2009, 15 (35) : 4356 - 4364
  • [45] Insulin resistance and insulin secretion in chronic hepatitis C virus infection
    Narita, R
    Abe, S
    Kihara, Y
    Akiyama, T
    Tabaru, A
    Otsuki, M
    JOURNAL OF HEPATOLOGY, 2004, 41 (01) : 132 - 138
  • [46] Insulin resistance and insulin secretion in chronic hepatitis C virus infection
    Narita, R
    Abe, S
    Kihara, Y
    Akiyama, T
    Tabaru, A
    Otsuki, M
    GASTROENTEROLOGY, 2004, 126 (04) : A686 - A686
  • [47] PREVALENCE OF AUTOANTIBODIES IN PATIENTS WITH CHRONIC HEPATITIS-C (CHC) - COMPARISON WITH BLOOD-DONORS
    SORBARA, R
    PIGOZZI, MG
    TEBALDI, P
    FRANCESCHINI, F
    LANZINI, A
    HEPATOLOGY, 1995, 22 (04) : 1547 - 1547
  • [48] MAJOR DEPRESSIVE DISORDER (MDD) IN PATIENTS WITH CHRONIC HEPATITIS C (CHC): PREVALENCE AND RISK FACTORS
    Araujo, R. F.
    da Cunha, L. R.
    Silva, L. D.
    Teixeira, R.
    Queiroz, D. D. M.
    Oliveira, L. M.
    Martins Filho, O. A.
    Neves, F. S.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S203 - S203
  • [49] Occult HBV infection in patients with chronic hepatitis C (CHC): Frequency and clinical impact
    Fabris, P
    Brown, D
    Tositti, G
    Bozzola, L
    Giordani, MT
    de Lalla, F
    Woong, C
    Dusheiko, GM
    JOURNAL OF HEPATOLOGY, 2001, 34 : 142 - 142
  • [50] Impact of introduction of Fibroscan® on the change in management of patients with Chronic Hepatitis C (CHC) infection
    Uchila, R.
    Kontorinis, N.
    Kong, J.
    Nazareth, S.
    Tuma, R.
    Chen, S. L.
    Cheng, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 22 - 23
12345